BRIEF-Regeneron and Sanofi announce Kevzara license application resubmission for review by FDA
* Regeneron and Sanofi announce Kevzara® (sarilumab) Biologics License Application resubmission accepted for review by U.S. FDA
Oct 10 Mobileiron Inc :
* Mobileiron raises Q3 guidance
* Sees Q3 revenue $41 million to $42 million
* Mobileiron inc sees q3 gross billings to be in range of $46.5-$47.5 million
* Mobileiron Inc - sees q3 NON-GAAP operating expenses are expected to be at low end of co's guidance of $41-$43 million
* Mobileiron Inc - "we believe we're on track to be cash flow positive in Q4"
* Q3 revenue view $40.4 million -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:
* Korea stocks, won down after Trump says trade deal needs change
BEIJING, April 28 Toshiba Corp's Westinghouse Electric Co unit will continue operating normally despite the ongoing Chapter 11 restructuring, an executive at the troubled company said on Friday.